Electronics aspirin refers to a medical technology driven by and for patients to relieve pain, e.g., migraines, cluster headaches, and other types of head and facial pain, which traditional aspirin cannot cure. Electronics aspirin is available only with a prescription; it is a relatively new technology that has made its way into the world of pain management. Easing the use of oral acetaminophen, an anti-inflammatory medication, for the treatment of pain, particularly severe headaches, may prove to be very beneficial to people suffering from migraines. Thus, with the increasing prevalence of headache, the demand for electronic aspirin is also increasing, driving the growth of the electronic aspirin market.
Request PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/26
According to the World Health Organization (WHO), worldwide, the prevalence among adults of current headache disorder (symptomatic) is about 50%. Migraine affects nearly 15% of the population or about one billion people worldwide. The prevalence of migraine is highest in North America, followed by South and Central America, Europe, Asia, and Africa. Around 3000 migraine attacks per million persons worldwide occur every day. This in turn is expected to augment the growth of the electronic aspirin market in these aforementioned regions.
As the use of Non-steroidal anti-inflammatory drugs for such conditions have shown to result in gastrointestinal or cardiac problems, this new technology, called electronic aspirin prolongs the lives of patients while reducing the complications. Electronic aspirin blocks the SPG signals at the first sign of a headache. Thus, there is an increasing demand for electronic aspirin around the world, driving the growth of the electronic aspirin market. Electronic aspirin requires a minimally-invasive surgery to implant the ATI neurostimulator permanently in the upper gum, above the second molar. It is placed on the side where the pain most frequently occurs.
Furthermore, electronic aspirin is a preferred option for migraine patients, as well as for those who get frequent headaches. It is believed to work by preventing the release of chemicals in the brain that stimulates the release of neurochemicals and hormones that signal pain. This new technology also seems to relieve the headache pain associated with migraine. It has been found that a variety of different pain-relieving medications affect people differently. One drawback of using electronic aspirin for the treatment of headache is the lack of therapeutic benefit for individuals using only minor head trauma, such as a simple bump on the head. This in turn is expected to restrain the growth of the electronic aspirin market.
Buy This Research Study Report For Quick Access@ https://www.coherentmarketinsights.com/insight/buy-now/26
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: [email protected]